30
Participants
Start Date
September 1, 2015
Primary Completion Date
July 1, 2016
Study Completion Date
July 1, 2016
Xenograft
group II will be treated with CAOT combined with bovine derived xenograft (Biogen, Biotecksrl Fermi, Arcugraro VI, Italy);
Bioactive glass
group III will be treated with CAOT combined with bioactive glass (Bio-Glass, Excellence Pharm Inc., Egypt).
King Abdelaziz University. Faculty of dentistry, Jeddah
King Abdulaziz University
OTHER